Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review
Liver International · 2025-04 · 45 (4)
DOI: 10.1111/liv.16127 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Liver International, online erschienen am 14.10.2024. Verfasst von Jennifer Cathcart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing public health problem. The secondary stage in MASLD is steatohepatitis (MASH), the co‐existence of steatosis and inflammation, a leading cause of progression to fibrosis and mortality. MASH resolution alone improves survival. Currently, MASH diagnosis is via liver biopsy. This study sought to evaluate the accuracy of imaging‐based tests for MASH diagnosis, which offer a non‐invasive method of diagnosis.
Methods
Eight academic literature databases were searched and references of previous systematic reviews and included papers were checked for additional papers. Liver biopsy was used for reference standard.
Results
We report on 69 imaging‐based studies. There were 31 studies on MRI, 27 on ultrasound, five on CT, 13 on transient elastography, eight on controlled attenuation parameter (CAP) and two on scintigraphy. The pathological definition of MASH was inconsistent, making it difficult to compare studies. 55/69 studies (79.71%) were deemed high‐risk of bias as they had no preset thresholds and no validation. The two largest groups of imaging papers were on MRI and ultrasound. AUROCs were up to 0.93 for MRE, 0.90 for MRI, 1.0 for magnetic resonance spectroscopy (MRS) and 0.94 for ultrasound‐based studies.
Conclusions
Our study found that the most promising imaging tools are MRI techniques or ultrasound‐based scores and confirmed there is potential to utilise these for MASH diagnosis. However, many publications are single studies without independent prospective validation. Without this, there is no clear imaging tool or score currently available that is reliably tested to diagnose MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
- Gastroenterology Department, Aberdeen Royal Infirmary, Aberdeen, UK.
- University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Targeting Intervention, University College London, London, UK.
ORCID-Profile: Jennifer Cathcart, Rachael Barrett, John F Dillon
Zitieren
APA
Cathcart, J., Barrett, R., Bowness, J. S., Mukhopadhya, A., Lynch, R., & Dillon, J. F. (2025). Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review. Liver International, 45(4). https://doi.org/10.1111/liv.16127
Vancouver
Cathcart J, Barrett R, Bowness JS, Mukhopadhya A, Lynch R, Dillon JF. Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review. Liver International. 2025;45(4). doi:10.1111/liv.16127
BibTeX
@article{Cathcart2025,
author = {Cathcart, Jennifer and Barrett, Rachael and Bowness, James S and Mukhopadhya, Ashis and Lynch, Ruairi and Dillon, John F},
title = {Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD : A Systematic Review},
journal = {Liver International},
year = {2025},
volume = {45},
number = {4},
doi = {10.1111/liv.16127}
}
EUVIMED